Clinical Trial Update: Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 1 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing inhaled insulin with subcutaneous human insulin in adults with Type 1 diabetes was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Exubera (insulin inhalation powder)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: TERMINATED | Results posted: 2010-01-26